期刊文献+

早期乳腺癌患者拉帕替尼联合紫杉醇化疗不良反应的护理 被引量:3

下载PDF
导出
摘要 总结17例早期乳腺癌患者用拉帕替尼和/或曲妥株单抗联合紫杉醇治疗的不良反应。主要观察新药拉帕替尼的不良反应,本组17例患者都有皮肤的改变,其中面部及全身皮疹9例,面部座疮5例,过敏性皮炎2例,皮肤瘙痒、皮肤颜色暗黑5例;手足综合征4例;Ⅰ°鼻出血4例;腹泻5例。护理要点:观察皮肤异常的部位、范围、性质、颜色,伴随症状,有无皮肤感染等并发症;观察指(趾)甲及手足皮肤病变的程度,有无疼痛等伴发症状,给予早期处理如外涂尿素软膏;鼻出血时,观察量及性质,嘱患者不要用力擤鼻,注意室内的空气湿度;腹泻时遵医嘱口服蒙脱石散、盐酸洛哌丁胺等。本组患者经对症处理后不良反应均好转。
出处 《护理学报》 2012年第10期70-71,共2页 Journal of Nursing(China)
  • 相关文献

参考文献2

二级参考文献33

  • 1FDA Approves Tykerb for Advanced Breast Cancer Patients[ EB/ OL]. FDA News P0744, March 13, 2007. http://www, fda. gov/bbs/topics/N EWS/2007/NEW01586. html.
  • 2Glaxo Smith Kline. Highlights of Prescribing Information:TYKERB (lapatinb) tables [ J/OL ]. http://www, fda. gov/cder/ foi/label/2007 /0220591bl. pdf.
  • 3JOHNSTON S R, I,EARY A. Lapatinib: a novrel EGFR/HER2 tyrosine kinase inhibitor for cancer [ J ] . Drugs 7bday (Barc ), 2006,42(7) :441-453.
  • 4GEYER C E, FORSTER J, LINDQUIST D, et al. Lapatinib plus capecitabine for ltER2-positive advanced breast cancer [ J ]. N Engl J Med,2006,355 (26) :2733-2743.
  • 5NAHTA R, YUAN L X, DU Y, et al. Lapatinib induces apoptosis in trastuzumab-resistant breast cancer cells: effects on insulinlike growth factor I signaling [ J ]. Mol Cancer Tiger,2007,6 (2) : 667-674.
  • 6KONECNY G E, PEGRAM M D, VENKATESAN N, et al. Activity of the dual kinase inhibitor lapatinib ( GW572016 ) against HER-2-overexpressing and trastuzumab-treated breast cancer cells [ J ]. Cancer Res ,2006,66 ( 3 ) : 1630-1639.
  • 7KELLY H, GRAHAM M, HUMES E, et al. Delivery of a healthy baby after first-trimester maternal exposure to lapatinlb [ J ]. Clln Breast Cancer,200,7(4) :339-341.
  • 8[1]Rowinsky E K.The ErbB family:targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors.Annu Rev Med,2004,55:433-457.
  • 9[2]Yarden Y,Sliwkowski M X.Untangling the ErbB signaling network.Nat Rev Mol Cell Biol,2001,2:127-137.
  • 10[3]Moy B,Goss P E.Lapatinib:current status and future directions in breast cancer.Oncologist,2006,11:1047-1057.

共引文献12

同被引文献8

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部